TEACHERS ADVISORS, LLC - ACCELERON PHARMA INC ownership

ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 1 filers reported holding ACCELERON PHARMA INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
TEACHERS ADVISORS, LLC ownership history of ACCELERON PHARMA INC
ValueSharesWeighting
Q1 2019$4,929,000
+15.1%
105,849
+7.6%
0.01%0.0%
Q4 2018$4,283,000
-56.6%
98,353
-43.0%
0.01%0.0%
Q3 2018$9,876,000
+145.8%
172,562
+108.4%
0.01%
+20.0%
Q2 2018$4,018,000
+27.8%
82,821
+3.0%
0.01%
+25.0%
Q1 2018$3,143,000
-7.5%
80,371
+0.4%
0.00%0.0%
Q4 2017$3,398,000
+55.5%
80,066
+36.7%
0.00%
+33.3%
Q3 2017$2,185,000
+24.1%
58,558
+1.1%
0.00%
+50.0%
Q2 2017$1,760,000
+44.3%
57,916
+25.7%
0.00%0.0%
Q1 2017$1,220,000
+5.9%
46,080
+2.1%
0.00%0.0%
Q4 2016$1,152,000
-27.4%
45,138
+3.0%
0.00%
-33.3%
Q3 2016$1,587,000
+6.5%
43,8420.0%0.00%0.0%
Q2 2016$1,490,000
+49.1%
43,842
+15.8%
0.00%
+50.0%
Q1 2016$999,000
-36.1%
37,851
+18.0%
0.00%
-33.3%
Q4 2015$1,564,000
+99.7%
32,070
+1.9%
0.00%
+50.0%
Q3 2015$783,000
-68.3%
31,464
-59.7%
0.00%
-60.0%
Q2 2015$2,469,000
-6.8%
78,040
+12.1%
0.01%0.0%
Q1 2015$2,649,000
-2.3%
69,5970.0%0.01%0.0%
Q4 2014$2,711,000
+28.6%
69,597
-0.1%
0.01%
+25.0%
Q3 2014$2,108,000
-11.0%
69,6970.0%0.00%
-20.0%
Q2 2014$2,368,000
+18.9%
69,697
+20.8%
0.01%
+25.0%
Q1 2014$1,991,000
+593.7%
57,698
+694.7%
0.00%
+300.0%
Q4 2013$287,0007,2600.00%
Other shareholders
ACCELERON PHARMA INC shareholders Q3 2023
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 1,449,300$59,537,000,0006.61%
Foresite Capital Management II, LLC 188,602$7,748,0004.36%
Foresite Capital Management III, LLC 254,923$10,472,0003.43%
Artal Group S.A. 1,500,000$61,620,0002.49%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,305,174$53,617,0001.93%
Asymmetry Capital Management, L.P. 82,473$3,388,0001.84%
QVT Financial LP 190,977$7,845,0001.66%
SECTORAL ASSET MANAGEMENT INC 269,396$11,067,0001.32%
Sofinnova Investments, Inc. 241,043$9,902,0000.91%
Novo Holdings A/S 119,708$4,918,0000.69%
View complete list of ACCELERON PHARMA INC shareholders